Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Veradigm Inc. (MDRX : NSDQ)

• Company Description    Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. Number of Employees: 8,000

• Price / Volume Information    Yesterday's Closing Price: $12.89 Daily Weekly Monthly 20 Day Moving Average: 1,564,659 shares Shares Outstanding: 109.26 (millions) Market Capitalization: $1,408.36 (millions) Beta: 1.01 52 Week High: $23.25 52 Week Low: $12.64 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -23.73% -22.50% 12 Week -27.91% -29.72% Year To Date -26.93% -28.95%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 222 MERCHANDISE MART PLAZA SUITE 2024 - CHICAGO,IL 60654 USA ph: 800-334-8534 fax: 313-322-9600 jenny.gelinas@allscripts.com http://www.allscripts.com

• General Corporate Information    Officers Paul M. Black - Chief Executive Officer and Director Michael A. Klayko - Chairman of the Board and Director Richard J. Poulton - President and Chief Financial Officer Elizabeth A. Altman - Director Mara G. Aspinall - Director Peer Information Veradigm Inc. (EVOL) Veradigm Inc. (RAMP) Veradigm Inc. (ALOT) Veradigm Inc. (TGHI) Veradigm Inc. (GNCMA) Veradigm Inc. (GSIC) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Technology Services Sector: Business Services CUSIP: 01988P108 SIC: 7373 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/22 Next Expected EPS Date: 03/01/23 Share - Related Items Shares Outstanding: 109.26 Most Recent Split Date: (:1) Beta: 1.01 Market Capitalization: $1,408.36 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.11 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.68 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 16.00% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/01/23

• Fundamental Ratios P/E Current FY Estimate: 18.96 Trailing 12 Months: 11.41 PEG Ratio: 1.18 Price Ratios Price/Book: 1.21 Price/Cash Flow: 4.68 Price / Sales: 1.68 EPS Growth vs. Year Ago Period: -4.76% vs. Previous Quarter: 66.67% Sales Growth vs. Year Ago Period: -58.86% vs. Previous Quarter: 0.66% ROE 12/31/22 - - 09/30/22 - 10.74 06/30/22 - 10.62 ROA 12/31/22 - - 09/30/22 - 6.68 06/30/22 - 6.31 Current Ratio 12/31/22 - - 09/30/22 - 3.20 06/30/22 - 3.23 Quick Ratio 12/31/22 - - 09/30/22 - 3.20 06/30/22 - 3.23 Operating Margin 12/31/22 - - 09/30/22 - 16.47 06/30/22 - 13.54 Net Margin 12/31/22 - - 09/30/22 - 7.25 06/30/22 - 5.90 Pre-Tax Margin 12/31/22 - - 09/30/22 - 14.59 06/30/22 - 11.84 Book Value 12/31/22 - - 09/30/22 - 10.62 06/30/22 - 10.31 Inventory Turnover 12/31/22 - - 09/30/22 - - 06/30/22 - - Debt-to-Equity 12/31/22 - - 09/30/22 - 0.17 06/30/22 - 0.17 Debt-to-Capital 12/31/22 - - 09/30/22 - 14.54 06/30/22 - 14.32

Powered by Zacks Investment Research ©